All Comments on OBHB Reload
Login to comment.
Lala King
Like · Reply
Queue 0.17 - 0.18 , always buy on weakness
Report
2 weeks · translate ·
Previous replies (6)
Alvin K
Hehehe buying volume are flowing in...
Like · 2 days · translate
Bob Ken
Retest to hit 0.18 and then 0.20 again
Like · Yesterday · translate
Bisaam Jebat
Like · Reply
CSPC Pharmaceutical Group Ltd's share price is soaring currently. OBHB is the next ~
Report
4 days · translate ·
Zikri Hafiq
Like · Reply
Plant baru kat Serendah dijangka siap 2nd half 2025 dan operasi start 2026. Confirm revenue akan terus meningkat
Report
2 weeks · translate ·
Previous replies (2)
Zikri Hafiq
Jangka OBHB mampu mencapai RM50 juta revenue tahun depan
Like · 1 week · translate
Bob Ken
OBHB has over 29 years of industry experience and expertise, the new plant will surely operate perfectly
Like · 1 week · translate
Infinite Realty Management
1 Like · Reply
Woww collab dengan CSPC..giant china pharma..nicely done OBHB..time to fly..
Report
1 month · translate ·
Mohd Jazuki
CSPC is also a listed company in Hong Kong. Quite strong and reliable
Like · 3 weeks · translate
Bob Ken
Quite looking forward to the new products they are going to launch
Like · 3 weeks · translate
Bisaam Jebat
Like · Reply
OBHB is poised for a stronger recovery, with signs that its performance and growth trends will continue to improve in the near future
Report
3 weeks · translate ·
Kenchi
Like · Reply
Public invest Buy call
Target Price: RM0.215, RM0.225
Last closing price: RM0.190
Potential return: 13.1%, 18.4%
Support: RM0.180
Stop Loss: RM0.160
Report
Show more
1 month · translate ·
Previous replies (2)
Benjamin Then
0.18 support is strong, steadyyy
Like · 3 weeks · translate
Kenchi
Monitor for rebound now, breakout signal coming anytime
Like · 3 weeks · translate
Zikri Hafiq
1 Like · Reply
Rasanya kita boleh mengharapkan lebih byk produk kesihatan termaju drpd OBHB dlm masa terdekat
Report
1 month · translate ·
Bob Ken
Like · Reply
Q3 report is out sooner than I thought. Nice earnings ~
Report
1 month · translate ·
Chun Yii Fatt
Of course, ni stock undervalue so far
Like · 1 month · translate
Goh Thiam Huat
2 Like · Reply
OB Holdings to partner HK's CSPC Pharmaceutical in product development. The collaboration aims to enhance product competitiveness, foster innovation, and expand applications within the functional food and supplement sectors across regional markets.
Report
1 month · translate ·
Mohd Jazuki
Nice, this shows that OBHB still has a solid foothold in Hong Kong
Like · 1 month · translate
Kenchi
2 Like · Reply
Target 1 achieved, next target 0.20
Report
1 month · translate ·
Luke Low
The rally still goes on, 20c shouldn't be a problem
Like · 1 month · translate
Load More